PT Soho Global Health Tbk (SOHO.JK)
IDR 680.0
(-1.47%)
IDR 680.0
(-1.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 371.34 Billion IDR | 4.1% |
| 2022 | 356.72 Billion IDR | -35.16% |
| 2021 | 550.17 Billion IDR | 219.67% |
| 2020 | 172.1 Billion IDR | 45.29% |
| 2019 | 118.45 Billion IDR | 139.83% |
| 2018 | 49.39 Billion IDR | 48.34% |
| 2017 | 33.29 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 99.2 Billion IDR | -21.5% |
| 2024 Q1 | 126.38 Billion IDR | 24.71% |
| 2024 Q3 | 115.85 Billion IDR | 16.79% |
| 2023 Q2 | 96.35 Billion IDR | 68.5% |
| 2023 FY | 371.34 Billion IDR | 4.1% |
| 2023 Q4 | 101.34 Billion IDR | -12.98% |
| 2023 Q3 | 116.45 Billion IDR | 20.86% |
| 2023 Q1 | 57.18 Billion IDR | -17.12% |
| 2022 Q4 | 68.99 Billion IDR | -26.88% |
| 2022 Q3 | 94.35 Billion IDR | 92.67% |
| 2022 Q2 | 48.97 Billion IDR | -66.08% |
| 2022 Q1 | 144.39 Billion IDR | 287.05% |
| 2022 FY | 356.72 Billion IDR | -35.16% |
| 2021 Q2 | 151.92 Billion IDR | 16.02% |
| 2021 Q3 | 229.99 Billion IDR | 51.39% |
| 2021 Q1 | 130.94 Billion IDR | 478.9% |
| 2021 FY | 550.17 Billion IDR | 219.67% |
| 2021 Q4 | 37.3 Billion IDR | -83.78% |
| 2020 Q2 | 97.89 Billion IDR | -24.3% |
| 2020 Q4 | 22.62 Billion IDR | 129.1% |
| 2020 Q3 | -77.72 Billion IDR | -179.4% |
| 2020 Q1 | 129.32 Billion IDR | 190.7% |
| 2020 FY | 172.1 Billion IDR | 45.29% |
| 2019 Q4 | 44.48 Billion IDR | 0.0% |
| 2019 Q1 | 69.76 Billion IDR | 0.0% |
| 2019 FY | 118.45 Billion IDR | 139.83% |
| 2018 FY | 49.39 Billion IDR | 48.34% |
| 2017 FY | 33.29 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 688.49 Billion IDR | 46.065% |
| PT Itama Ranoraya Tbk | 5.19 Billion IDR | -7043.342% |
| PT Kimia Farma (Persero) Tbk | -1485.56 Billion IDR | 124.997% |
| PT Millennium Pharmacon International Tbk | 33.08 Billion IDR | -1022.299% |